Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Preferred Shares Issued Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

cbdMD (YCBD) Acquisitions (2018 - 2019)

cbdMD's Acquisitions history spans 2 years, with the latest figure at -$250740.0 for Q3 2019.

On a quarterly basis, Acquisitions changed N/A to -$250740.0 in Q3 2019 year-over-year; TTM through Jun 2020 was -$250740.0, a 121.48% decrease, with the full-year FY2019 number at $916555.0, changed N/A from a year prior.
Acquisitions hit -$250740.0 in Q3 2019 for cbdMD, down from -$10572.0 in the prior quarter.
Over the last five years, Acquisitions for YCBD hit a ceiling of $1.2 million in Q4 2018 and a floor of -$250740.0 in Q3 2019.